Search

Author/Creator García‐Alfonso, Pilar

1. Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer. (19th August 2018)

Authors:
Fogelman, David; Cubillo, Antonio; García‐Alfonso, Pilar; Mirón, María Luisa Limón; Nemunaitis, John; Flora, Daniel; Borg, Christophe; Mineur, Laurent; Vieitez, Jose M.; Cohn, Allen; Saylors, Gene; Assad, Albert; Switzky, Julie; Zhou, Li; Bendell, Johanna
Journal:
Cancer medicine
Issue:
Volume 7:Number 11(2018:Nov.)
Page Start:
5382
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial). (17th August 2018)

Authors:
García‐Alfonso, Pilar; Benavides, Manuel; Falcó, Esther; Muñoz, Andrés; Gómez, Auxiliadora; Sastre, Javier; Rivera, Fernando; Montagut, Clara; Salgado, Mercedes; López‐Ladrón, Amelia; López, Rafael; Ruiz de Mena, Inmaculada; Durán, Gema; Aranda, Enrique
Journal:
Oncologist
Issue:
Volume 23:Number 11(2018)
Page Start:
1271
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC). (30th September 2019)

Authors:
Bendell, Johanna C.; Sauri, Tamara; Gracián, Antonio Cubillo; Alvarez, Rafael; López‐López, Carlos; García‐Alfonso, Pilar; Hussein, Maen; Miron, Maria‐Luisa Limon; Cervantes, Andrés; Montagut, Clara; Vivas, Cristina Santos; Bessudo, Alberto; Plezia, Patricia; Moons, Veerle; Andel, Johannes; Benno...
Journal:
Oncologist
Issue:
Volume 25:Number 3(2020)
Page Start:
e451
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search